C-19/long COVID/post-vaccination syndrome & Autoimmunity

18% of patients with post-COVID-19 vaccination syndrome were found to have autoantibodies against peripheral nerve structures

Dec 10, 2024

This study has shown that serum prevalence of autoreactive IgGs against peripheral nerve structures was significantly higher in PCVS patients than in healthy controls. IgG binding was directed against axons, paranodes, Schmidt-Lanterman incisures, and Schwann cell nuclei.

Differences in the concentrations of autoantibodies against receptors involved in autonomic regulation between individuals with post-COVID-19 vaccination syndrome and vaccinated healthy subjects could be related to dysautonomia

Nov 21, 2023

The concentrations of autoantibodies against receptors involved in autonomic regulation and serum levels of IL-6/IL-8 can distinguish individuals with post-COVID-19 vaccination syndrome from healthy vaccinated individuals.

29% of healthcare workers vaccinated with three doses of mRNA COVID-19 vaccines had de novo production of antinuclear antibodies

Oct 21, 2023

A significant proportion (29%) of healthcare workers developed de novo production of antinuclear antibodies after three mRNA COVID-19 vaccines. The most prevalent was a homogeneous pattern of ANA.

Other Entries

Temporal dynamics of anti-chemokine autoantibodies in COVID-19 and long-COVID syndrome

Jul 20, 2023

The findings suggest that higher levels of autoantibodies directed against specific chemokines are associated with favorable disease outcomes in COVID-19 convalescents.